ELCI34 Stock Price and Chart — BMFBOVESPA:ELCI34

Overview

Financials News Ideas Discussions Technicals Seasonals Bonds

Key facts today

Estée Lauder's lawsuit is now in the discovery phase, amid a significant drop in stock value after its May 2023 report of weaker sales and reduced profit outlook.

Canaccord Genuity has a 'Hold' rating on Estée Lauder (EL) and lowered its price target from $70 to $62 per share, with an average target of $68.69.

Estée Lauder is seen as undervalued due to recent struggles in the beauty market. Cost-saving measures and a turnaround strategy are key factors in this view.

Analyze the impact Analyze the impact

About Estee Lauder Companies, Inc. (The)

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. Its channels consist of department stores, multi-brand retailers, upscale perfumeries and pharmacies, and prestige salons and spas. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.